Anti-Obesity Prescription Drugs Market to Represent a Value of over US $1,000 Mn by the End of 2026
Growing prevalence of obesity continues to impact health of the patients adversely. Prevalence of obesity is bound to various factors such as improper diet, chronic stress and intake of medications for diabetes and depression. Untreated obesity has led to health issues such as diabetes, sleep apnea, high blood pressure, heart disease, cancer, osteoarthritis and psychosocial effects.
View full press release